Home > Healthcare > Biotechnology > Biotechnology R&D > DNA Synthesis Market

DNA Synthesis Market Trends

Report ID: GMI6000
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

DNA Synthesis Market Trends

Investments in DNA synthesis by market players have been increasing over the years as the field of synthetic biology and genetic engineering continues to advance. High investments in research to unveil novel technology will positively influence the market growth. For instance, in 2021, Molecular Assemblies received USD 25.8 million funding from Casdin Capital to enhance enzymatic DNA synthesis technology. Similarly, in March 2021, Twist Bioscience announced USD 100 million private placement investment from several investors, including Casdin Capital, Fidelity Management & Research Company, and Viking Global Investors to advance their DNA synthesis platform. Thus, the increasing investments in DNA synthesis industry is expected to fuel the market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

In 2023, the global DNA synthesis market was valued at USD 4.1 billion and will grow at 19.5% CAGR from 2024 to 2032, attributed to rising demand for research in drug discovery and personalized medicine.

The oligonucleotide synthesis segment amassed 52.6% of the DNA synthesis market share in 2022, on account of the increasing utilization of oligonucleotide synthesis for synthetic biology.

North America DNA synthesis market held over 38.4% market share in 2022, attributed to the robust presence of leading industry players in the region.

Some of the leading DNA synthesis market players include Eton Bioscience, IBA GmbH, Integrated DNA Technologies, Inc., GenScript Biotech Corporation, LGC Biosearch Technologies, Eurofins Scientific, Quintara Biosciences, and OriGene Technologies, Inc., among others.